FRIDAY, May 16, 2025 (HealthDay News) — A baby born with a rare and deadly genetic disease is the world's first known patient to receive an experimental gene editing treatment designed just for him.

Before Baby KJ was six months old, doctors at Children’s Hospital of Philadelphia injected a gene-editing therapy built for ...

A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment made just for him. Researchers described the case in a new study, ...

An infant with a rare metabolic disease became the world’s first patient to be treated with a personalized CRISPR gene-editing treatment in a landmark study between Penn Medicine and the Children’s ...

Researchers at Mass General Brigham in Boston have designed a custom gene editing technique that corrected the mutation behind a rare blood vessel disease in mice, paving the way for further ...

Expanding on the Cooperative Center of Excellence in Hematology (CCEH) at Fred Hutchinson Cancer Center’s expertise in providing Human CD34+ HSPCs, we have established a high-efficiency and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

This event was produced in partnership with Cellectis by Scientific American Custom Media, a division separate from the magazine’s board of editors. After decades of lab research, gene editing has ...

Scientists from Children’s Hospital of Philadelphia, Penn Medicine and other partners created a therapy that targeted KJ’s specific genetic mutation. HealthDay News — A baby born with a rare and ...